Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer

In 2008, the GEC ESTRO Gyn network launched the first multiinstitutional, observational, and prospective international study on MRI-guided brachytherapy in locally advanced cervical cancer patients (EMBRACE-I). EMBRACE-I was followed by EMBRACE-II from 2016 and ongoing. Among the aims of the EMBRACE studies are to benchmark morbidity outcomes and develop dose-volume effects and predictive models for morbidity. The EMBRACE studies collect both physician (CTCAE v.3) and patient (EORTC QLQ-C30/CX24) reported outcomes, including baseline information, in a regular follow-up schedule.

Source: Brachytherapy - September 21, 2020 Category: Cancer & Oncology Authors: Kathrin Kirchheiner, St éphanie Smet, Sofia Spampinato, Nina B.K. Jensen, Anders Schwartz Vittrup, Lars Fokdal, Dina Najjari-Jamal, Henrike G. Westerveld, Jacob C. Lindegaard, Christian Kirisits, Astrid De Leeuw, Maximilian P. Schmid, Li Tee Tan, Remi A. Source Type: research